In PAAD, high expression of PTHLH, MMP3, MMP1, MMP10 and THBS2 was significantly correlated with poor survival, whereas only MMP1 and NXPH4 are associated with low survival in BRCA patients (Figure S7C). This evidence concerns the gene MMP1 and pancreatic adenocarcinoma.